Full Text
The Full Text of this article is available as a PDF (1.9 MB).
editorial . 2006 Nov 1;6(6):526–528. doi: 10.7861/clinmedicine.6-6-526
Targeting cancers with tyrosine kinase inhibitors: lessons learned from chronic myeloid leukaemia
Tariq I Mughal
1, John M Goldman
2
Tariq I Mughal, MD MRCP FACP
1Division of Hematology and Stem Cell Transplantation, University of Texas Southwestern, School of Medicine, Dallas, Texas, USA
Professor of Medicine and Hematology
Find articles by Tariq I Mughal
John M Goldman, DM FRCP
2Biology, Imperial College London
Emeritus Professor of Leukaemia Biology
Find articles by John M Goldman
1Division of Hematology and Stem Cell Transplantation, University of Texas Southwestern, School of Medicine, Dallas, Texas, USA
2Biology, Imperial College London
Roles
Tariq I Mughal: MD MRCP FACP, Professor of Medicine and Hematology
John M Goldman: DM FRCP, Emeritus Professor of Leukaemia Biology
© 2006 Royal College of Physicians
PMCID: PMC4952759 PMID: 17228548